Roger D Blair, Christine Piette Durrance, Tirza J Angerhofer

Antitrust Policy in Health Care Markets

• Gebundenes Buch

Produktbeschreibung

"In Economics 101, we learn that competition and competitive markets provide the biggest bang for the buck. In a perfectly competitive world, scarce resources are allocated in the most efficient way; the goods and services that are valued most highly are produced in the right quantities and are priced appropriately. Perfectly competitive markets, therefore, maximize social welfare, which is the sum of consumer surplus and producer surplus. Market imperfections can impede the competitive process and introduce inefficiencies which, in time, can reduce the well-being of society. These imperfections include externalities, public goods, asymmetric information, and monopoly power. The public policy response to these market failures is to promote and preserve competition. Concerns over market imperfections are also present in the U.S. health care sector. Departures from competition can lead to poor quality care and cause losses in the hundreds of billions of dollars"--

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Cambridge University Press
• Seitenzahl: 350
• Erscheinungstermin: 8. Dezember 2022
• Englisch
• Abmessung: 229mm x 152mm x 29mm
• Gewicht: 871g
• ISBN-13: 9781316515204
• ISBN-10: 1316515206
• Artikelnr.: 63978903

Autorenporträt

Roger D. Blair is Professor of Economics at the University of Florida.

Inhaltsangabe

1. Health care markets and competition policy
2. Antitrust policy in the United States
Section I. Monopoly: 3 Patents and monopoly pricing of pharmaceuticals
4. Patents and exclusionary product hopping
5. Bundled discounts and peace health
Section II. Seller Cartels: 6. Collusion in health care markets
7. Collusion in generic drug markets
8. The hatch-waxman act, patent infringement suits, and reverse payments
Appendix
The economics of settlements
9. The alleged insulin conspiracy
10. Licensing of health care professionals
Section III. Monopsony: 11. Monopsony, dominant buyers, and oligopsony
12. Countervailing power - physician collective bargaining
13. Group purchasing organizations, monopsony, and antitrust policy
Section IV. Buyer Cartels: 14. Collusion in the nurse labor market
15. Collusion in the oocyte market
16. No-Poaching agreements and antitrust policy
Section V. Mergers and Acquisitions: 17. The economics of horizontal mergers
18. Horizontal merger policy
19. The economic theory of vertical integration
20. Vertical merger policy
21. Concluding remarks.